How Much Upside is Left in Rigel (RIGL)? Wall Street Analysts Think 28.28%
Portfolio Pulse from
Wall Street analysts suggest a potential 28.3% upside for Rigel Pharmaceuticals (RIGL) based on average price targets. Positive earnings estimate revisions could support this potential increase.
November 19, 2024 | 4:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Rigel Pharmaceuticals (RIGL) has a potential upside of 28.3% according to Wall Street analysts' average price targets. Positive earnings estimate revisions may support this potential increase.
The article highlights that Wall Street analysts have set an average price target indicating a 28.3% upside for RIGL. Additionally, the positive trend in earnings estimate revisions suggests that the stock could indeed experience an upward movement, making this news highly relevant and important for investors in RIGL.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100